Study of Safety, Tolerability and Efficacy of PBKR03 in Pediatric Subjects With Early Infantile Krabbe Disease

NCT04771416 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

SUSPENDED

Status

24

Enrollment

INDUSTRY

Sponsor class

Stopped The study was stopped due to changes in the company strategy.

Conditions

Leukodystrophy, Globoid Cell

Interventions

BIOLOGICAL: PBKR03

Sponsor

Gemma Biotherapeutics